Epi4Dogs hosted an EPI Seminar on September 6, 2017 in Lebanon, TN
Below are the PowerPoint slide presentations
We are working on uploading a video of the entire EPI Seminar.... however, please know that the sounds/volume is very faint. We will know better next time how to set the video recording equipment up better......
The EPI Seminar Presenters
Dr. David A.
Williams, MA VetMB PhD, DACVIM-SAIM DECVIM-CA, Professor, Small Animal
Internal Medicine, College of Veterinary Medicine, University of Illinois
David Williams founded the “GI Lab” in 1985 at the University of Florida, when he introduced assay of serum trypsin-like immunoreactivity (TLI) in the dog to the United States. His research has been focused on the development and application of new tests for gastrointestinal diseases, particularly those affecting the pancreas, small intestine, stomach and liver of dogs and cats. Students and staff working in his other GI Laboratories at Kansas State, Purdue, and most recently Texas A&M Universities established several other novel tests for gastrointestinal diseases for use by veterinarians internationally. These included feline serum TLI, canine and feline serum pancreatic lipase (PLI), canine and feline fecal alpha1-proteinase inhibitor, unconjugated serum bile acids, canine thyroid stimulating hormone (TSH), and canine and feline serum cobalamin and folate assays.
He received his veterinary degree from the University of Cambridge and his PhD from the University of Liverpool (where he first developed the canine TLI assay). He was an intern and resident at the University of Pennsylvania, and has held Faculty positions at the University of Florida, Kansas State University, Purdue University, Texas A&M University (where he served as Head of Small Animal Clinical Sciences), and currently at the University of Illinois (where he served as Head of Veterinary Clinical Medicine). He continues to work as an Adjunct Professor and consultant with the GI Lab at Texas A&M University, providing telephone consultations with veterinarians regarding management of patients diagnosed using the GI Lab services.
Olesia C. Kennedy, President, Epi4Dogs Foundation, Inc.
Epi4Dogs May 2008. Established due to
frustration with the lack of available cohesive information about EPI (exocrine
pancreatic insufficiency) in dogs. She has worked tirelessly bringing awareness
to EPI working with volunteers nationwide educating the public, working with
the veterinary community, assisting multiple veterinary researchers here and
abroad with studies pertaining to EPI, manages a 24/7 support group for EPI pet
owners, created and maintains an EPI educational website, has published
multiple articles on EPI, when possible assist those financially struggling due
to EPI expenses, and maintains the only
EPI registry in the world. Previous experience Duke University Medical Center, NC, and also at Brinker Capital, NC as a
Financial Research Analyst. Earned Canine Search & Rescue SAR II & III
National Tech Certification. Volunteered as a canine handler in NC, Assisted
with state-wide law enforcement with missing persons and recovery searches.
Currently President of Epi4Dogs Foundation, Inc., a 501c3 Non-Profit Public
Educational Charity organization and manages a Forum (support group) membership
of 3100. Epi4Dogs also has the largest
EPI Facebook presence, and as of May 2017 developed a social media
presence on Twitter and Instagram. Epi4Dogs currently has an Executive Board of
4 and 14 International Adjunct Board members.
Dr. Patrick Barko, DVM, Resident, Small
Animal Internal Medicine, College of Veterinary
Medicine, University of Illinois at Urbana Champaign
Barko graduated from the Washington State University College of Veterinary
Medicine in 2013 and completed a rotating internship in small animal medicine
and surgery at the University of Illinois. As a small animal internal medicine
resident at the University of Illinois Veterinary Teaching Hospital, he is
working with Dr. David Williams and other researchers on a number of innovative
investigative projects. His research interests include small animal
gastroenterology, developmental microbiomics, and the application of cutting
edge technologies, including metabolomics and DNA sequencing technology, to
veterinary clinical research